Do Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease?

James B. Kaper, Timothy K. McDaniel, Karen G. Jarvis, Oscar Gomez-Duarte, Genetics of Virulence of Enteropathogenic E. coli Advances in Experimental Medicine and Biology. ,vol. 412, pp. 279- 287 ,(1997) , 10.1007/978-1-4899-1828-4_47

Paul Dean, Sabrina Mühlen, Sabine Quitard, Brendan Kenny, The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector Cellular Microbiology. ,vol. 12, pp. 1308- 1321 ,(2010) , 10.1111/J.1462-5822.2010.01469.X

Marie‐Catherine Grès, Bernard Julian, Martine Bourrié, Viviane Meunier, Claude Roques, Marion Berger, Xavier Boulenc, Yves Berger, Gérard Fabre, Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line : Comparison with the parental Caco-2 cell line Pharmaceutical Research. ,vol. 15, pp. 726- 733 ,(1998) , 10.1023/A:1011919003030

C Canil, I Rosenshine, S Ruschkowski, M S Donnenberg, J B Kaper, B B Finlay, Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infection and Immunity. ,vol. 61, pp. 2755- 2762 ,(1993) , 10.1128/IAI.61.7.2755-2762.1993

James B. Kaper, James P. Nataro, Harry L. T. Mobley, Pathogenic Escherichia coli Nature Reviews Microbiology. ,vol. 2, pp. 123- 140 ,(2004) , 10.1038/NRMICRO818

Donna A. Volpe, Variability in Caco-2 and MDCK cell-based intestinal permeability assays† Journal of Pharmaceutical Sciences. ,vol. 97, pp. 712- 725 ,(2008) , 10.1002/JPS.21010

Masami Miyake, Miyuki Hanajima, Takeshi Matsuzawa, Chiho Kobayashi, Masayoshi Minami, Akio Abe, Yasuhiko Horiguchi, Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli. Biochemical and Biophysical Research Communications. ,vol. 337, pp. 922- 927 ,(2005) , 10.1016/J.BBRC.2005.09.130

Paul Dean, Brendan Kenny, Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein Molecular Microbiology. ,vol. 54, pp. 665- 675 ,(2004) , 10.1111/J.1365-2958.2004.04308.X

Marie-Hélène Ruchaud-Sparagano, Marc Maresca, Brendan Kenny, Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cellular Microbiology. ,vol. 9, pp. 1909- 1921 ,(2007) , 10.1111/J.1462-5822.2007.00923.X

Y. Sambuy, I. De Angelis, G. Ranaldi, M. L. Scarino, A. Stammati, F. Zucco, The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics Cell Biology and Toxicology. ,vol. 21, pp. 1- 26 ,(2005) , 10.1007/S10565-005-0085-6